Curebound is a 501c3 philanthropic organization that raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application.
Launched in 2021, Curebound represents a partnership and expansion between two highly respected San Diego cancer organizations – Padres Pedal the Cause and the Immunotherapy Foundation—that have raised over $26 million since 2013 to fund more 80+ unique cancer research projects between San Diego’s exceptional research institutions.
Curebound investments in cancer research projects are led by a world-class Scientific Advisory Board (SAB) that aligns deep experience in basic and academic research with industry leaders who bring proven track records in translating basic discoveries to clinical and commercial stages. Under the SAB’s guidance, Curebound curates the most promising research opportunities and brings together highly specialized collaborative teams for each project. Curebound brings together all major cancer research institutes in San Diego including UCSD Moores, the Salk Institute, Sanford Burnham Prebys, Scripps Translational Research, La Jolla Immunology and Rady’s Children’s Hospital.
Curebound is committed to investing $100 million into game-changing collaborative cancer research by the end of the decade.
For more information, please visit http: https://www.curebound.org